GLOW LIFETECH CORP. (9DO) - Total Liabilities
Based on the latest financial reports, GLOW LIFETECH CORP. (9DO) has total liabilities worth €1.11 Million EUR (≈ $1.30 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore GLOW LIFETECH CORP. long-term investment allocation to see how much of total assets are deployed in long-term investments.
GLOW LIFETECH CORP. - Total Liabilities Trend (2021–2025)
This chart illustrates how GLOW LIFETECH CORP.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 9DO asset base.
GLOW LIFETECH CORP. Competitors by Total Liabilities
The table below lists competitors of GLOW LIFETECH CORP. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bio-Gene Technology Ltd
AU:BGT
|
Australia | AU$307.71K |
|
Zephyr Minerals Ltd
V:ZFR
|
Canada | CA$250.96K |
|
Earthworks Industries Inc
V:EWK
|
Canada | CA$2.99 Million |
|
PAVmed Inc
NASDAQ:PAVM
|
USA | $12.28 Million |
|
Highway Holdings Limited
NASDAQ:HIHO
|
USA | $1.87 Million |
|
ZhongDe Waste Technology AG
F:ZEF
|
Germany | €18.24 Million |
|
Vinvest Capital Holdings Bhd
KLSE:0069
|
Malaysia | RM45.56 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down GLOW LIFETECH CORP.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of GLOW LIFETECH CORP. to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GLOW LIFETECH CORP.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GLOW LIFETECH CORP. (2021–2025)
The table below shows the annual total liabilities of GLOW LIFETECH CORP. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €1.21 Million ≈ $1.41 Million |
+4.88% |
| 2024-12-31 | €1.15 Million ≈ $1.35 Million |
-51.70% |
| 2023-12-31 | €2.38 Million ≈ $2.78 Million |
+104.10% |
| 2022-12-31 | €1.17 Million ≈ $1.36 Million |
+255.79% |
| 2021-12-31 | €328.03K ≈ $383.50K |
-- |
About GLOW LIFETECH CORP.
Glow Lifetech Corp., an ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based capsules, and market-ready products, as well as precision-dosed capsules. The company has exclusive North American rights for the pr… Read more